MedTrace Logo

Effectiveness of the Cytokine Hemadsorption on Sepsis

NCT05057455 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 39

Last updated 2021-09-27

No results posted yet for this study

Summary

In this prospective study, we aimed to compare the laboratory and clinical results of cytokine hemadsorption as an immunomodulation therapy in ICU patients diagnosed with sepsis or septic shock.

Conditions

  • Interleukin-6

Interventions

PROCEDURE

cytokine hemadsorption

the laboratory and clinical results of cytokine hemadsorption as an immunomodulation therapy in ICU patients diagnosed with sepsis or septic shock.

Sponsors & Collaborators

  • Biruni University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2020-12-30
Completion
2021-02-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05057455 on ClinicalTrials.gov